Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Evaluate the Safety and Effectiveness of Cimzia in Rheumatoid Arthritis and Crohn's Disease Patients When Using a Comprehensive Program of Tuberculosis Screening and Monitoring

NCT01577264 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT01577264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01577264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Evaluate the Safety and Effectiveness of Cimzia in Rheumatoid Arthritis and Crohn's Disease Patients When Using a Comprehensive Program of Tuberculosis Screening and Monitoring
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Terminated
Start date
August 31, 2011
Completion date
October 31, 2015
Enrollment
199 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, rheumatoid arthritis